Active participation of CCR5+CD8+ T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease

Journal of Clinical Investigation

Volumn 104, Issue 1, 1999, Pages 49-57

  Murai, Masako ^a,b   Yoneyama, Hiroyuki ^a,b   Harada, Akihisa ^a   Yi, Zhang ^a   Vestergaard, Christian ^a   Guo, Baoyu ^c   Suzuki, Kenji ^b   Asakura, Hitoshi ^b   Matsushima, Kouji ^a,d  

^a UNIVERSITY OF TOKYO   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR5;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; LIVER INJURY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE SUBPOPULATION;

EID: 0032740991     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI6642     Document Type: Article

References (37)

1. Ferrara, J.L.M., and Deeg, H.J. 1991. Graft-versus-host disease. N. Engl. J. Med 324:667-674.
2. Gleichmann, E., Pals, S.T., Rolink, A.G., Radaszkiewicz, T., and Gleichmann, H. 1984. Graft-versus-host reactions: clues to the ethiopathology of a spectrum of immunological diseases. Immunol. Today. 5:324-332.
3. Rus, V., Svetic, A., Nguyen, P., Gause, W.C., and Via, C.S. 1995. Kinetics of Th1 and Th2 cytokine production during the early course of acute and chronic murine graft-versus-host disease. J. Immunol. 155:2396-2406.
4. Bobe, P., et al. 1997. Fas-mediated liver damage in MRL hemopoietic chimeras undergoing lpr-mediated graft-versus-host disease. J. Immunol. 159:4197-4204.
5. Baker, B.M.B., Altman, N., Podack, E., and Levy, R.B. 1996. The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice. J. Exp. Med. 183:2645-2656.
6. Braun, M.Y., Lowin, B., French, L., Acha-Oreba, H., and Tschopp, J. 1996. Cytotoxic T cells deficient in both functional Fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease. J. Exp. Med. 183:657-661.
7. Williamson, E., Garside, P., Bradley, A., More, I.A.R., and Mowat, A.M. 1997. Neutralizing IL-12 during induction of murine acute graft-versus-host disease polarizes the cytokine profile toward a Th2-type alloimmune response and confers long term protection from disease. J. Immunol. 159:1208-1215.
8. Brok, H.P.M., Heidt, P.J., Van der Meide, P.H., Zurcher, C., and Vossen, J.M. 1993. Interferon-gamma prevents graft-versus-host disease after allogeneic bone marrow transplantation in mice. J. Immunol. 151:6451-6459.
9. Shustov, A., Nguyen, P., Finkelman, F., Elkon, K.B., and Via, C. S. 1998. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-γ production. J. Immunol. 161:2848-2855.
10. Via, S.C., Nguyen, P., Shustov, A., Drappa, J., and Elkon, K.B. 1996. A major role for the Fas pathway in acute graft-versus-host disease. J. Immunol. 157:5387-5393.
11. Allen, D.R., Staley, T.A., and Sidman, C.L. 1993. Differential cytokine expression in acute and chronic murine graft-versus-host-disease. Eur. J. Immunol. 23:333-337.
12. Ellison, C.A., Fischer, J.M.M., HayGlass, K.T., and Gartner, J.G. 1998. Murine graft-versus-host disease in an F1-hybrid model using IFN-γ gene knockout donors. J. Immunol. 161:631-640.
13. Baggiolini, M. 1998. Chemokines and leukocyte traffic. Nature. 392:565-568.
14. Butcher, E.C., and Picker, L.J. 1996. Lymphocyte homing and homeostasis. Science. 272:60-66.
15. Littman, R.D. 1998. Chemokine receptors: keys to AIDS pathogenesis? Cell. 93:677-680.
16. Rollins, J.B. 1997. Chemokines. Blood. 90:909-928.
17. Farber, J.M. 1997. Mig and IP-10 chemokines that target lymphocytes. J. Leukoc. Biol. 61:246-257.
18. Loetscher, P., et al. 1998. CCR5 is characteristic of Th1 lymphocytes. Nature. 391:344-345.
19. Qin, S., et al. 1998. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J. Clin. Invest. 101:746-754.
20. Rottman, J.B., et al. 1997. Cellular localization of the chemokine receptor CCR5. Am. J. Pathol. 151:1341-1351.
21. Yoneyama, H., et al. 1998. Pivotal role of TARC, a CC chemokine, in bacteria-induced fulminant hepatic failure in mice. J. Clin. Invest. 102:1933-1941.
22. Gibson, U.E.M, Heide, C.A., and Williams, P.M. 1996. A novel method for real time quantitative RT-PCR. Genome Res., 6:995-1001.
23. Zhou, Y., et al. 1998. Impaired macrophage function and enhanced T cell-dependent immune response in mice lacking CCR5, the mouse homologue of the major HIV-1 coreceptor. J. Immunol. 160:4018-4025.
24. Su, S.-B., Mukaida, N., Wang, J.-B., Nomura, H., and Matsushima, K. 1996. Preparation of specific polyclonal antibodies to a C-C chemokine teceptor, CCR1, and determination of CCR1 expression on various types of leukocytes. J. Leukoc. Biol. 60:658-666.
25. Saitoh, T., et al. 1990. Depletion of CD8+ cells exacerbates organ-specific autoimmune diseases induced by CD4+ T cells in semiallogeneic hosts with MHC class II disparity. J. Immunol. 145:3268-3275.
26. Suzuki, K., Narita, T., Yui, R., Asakura, H., and Fujiwara, M. 1994. Mechanism of the induction of autoimmune disease by graft-versus-host reaction. Lab. Invest. 70:609-619.
27. Williamson, E., Garside, P., Bradley, J.A., and Mowat, A.M. 1996. IL-12 is a central mediator of acute graft-versus-host disease in mice. J. Immunol. 157:689-699.
28. Saito, K., et al. 1998. Involvement of CD40 ligand-CD40 and CTLA4-B7 pathways in murine acute graft-versus-host disease induced by allogeneic T cells lacking CD28. J. Immunol. 160:4225-4231.
29. Bonecchi, R., et al. 1998. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J. Exp. Med. 187:129-134.
30. Taub, D.D., Conlon, K., Lioyd, A.R., Oppenheim, J.J., and Kelvin, D.J. 1993. Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1α and MIP-1β. Science. 260:355-358.
31. Fowler, D.H., Kurasawa, K., Husebekk, A., Cohen, P.A., and Gress, R.E. 1994. Cells of the Th2 cytokine phenotype prevent LPS-induced lethality during murine graft-versus-host reaction. J. Immunol. 152:1004-1013.
32. Kreneger, W., Snyder, K.M., Byon, J.C.H., Falzarano, G., and Ferrara, J.L.M. 1995. Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimenral acute graft-vetsus-host disease. J. Immunol. 155:585-593.
33. Liu, Y., and Janeway, C.A. 1990. Interferon-gamma plays a critical role in induced cell death of effector T cell: a possible third mechanism of self-tolerance. J. Exp. Med. 172:1735-1739.
34. Novelli, F., et al. 1994. Environmental signals influencing expression of the IFN-γ receptor on human T cells control whether IFN-γ promotes proliferation or apoptosis. J. Immunol. 152:496-504.
35. Novelli, F., et al. 1997. Expression and role in apoptosis of alpha- and beta-chains of the IFN-gamma receptor on human Th1 and Th2 clones. J. Immunol. 159:206-213.
36. Yang, Y.-G., Dey, B.R., Sergio, J.J., Peason, D.A., and Sykes, M. 1998. Donor-derived interferon-γ is required for inhibition of acute graft-versus-host disease by interleukin 12. J. Clin. Invest. 102:2126-2135.
37. Yang, Y.-G., et al. 1997. Interleukin-12 prevents the graft-versus-host leukemia effect of allogeneic CD8 T cells while inhibiting CD4-dependent graft-versus-host disease in mice. Blood. 90:4651-4660.